Published: Apr 26, 2026
Written by Klarity Editorial Team
Published: Apr 26, 2026

If you’re exploring treatment options for Binge Eating Disorder (BED), you may have heard that medications like Topamax (topiramate) or Wellbutrin (bupropion) can help manage symptoms. But navigating insurance coverage for these medications—especially when they’re prescribed off-label—can feel overwhelming.
The good news? Most insurance plans do cover generic versions of Topamax and Wellbutrin, even when prescribed for BED. Understanding your coverage, potential costs, and how to maximize your benefits can help you access the treatment you need without breaking the bank.
Topamax (topiramate) is an anticonvulsant originally approved for epilepsy and migraine prevention. However, research has shown it can reduce binge eating episodes and help with weight management in people with BED.
Wellbutrin (bupropion) is an antidepressant commonly prescribed for depression and smoking cessation. It’s also used off-label for BED because it may help reduce cravings and improve mood regulation—both key factors in binge eating behavior.
While neither medication is FDA-approved specifically for BED, healthcare providers often prescribe them ‘off-label’ when clinical evidence supports their effectiveness. Off-label prescribing is legal, common, and generally covered by insurance when medically appropriate.
Binge Eating Disorder affects millions of Americans, causing significant physical and emotional distress. Treatment typically combines psychotherapy (like Cognitive Behavioral Therapy) with medication when appropriate.
Unlike Vyvanse—the only FDA-approved medication for BED, which is a controlled substance requiring stricter prescribing protocols—Topamax and Wellbutrin are non-controlled medications. This makes them easier to prescribe via telehealth and often simpler to get covered by insurance without extensive prior authorization.
Most commercial health plans—including major insurers like UnitedHealthcare, Cigna, Blue Cross Blue Shield, Aetna, Humana, and Kaiser—cover generic topiramate and bupropion as part of their standard pharmacy benefits.
Here’s what typical coverage looks like:
| Medication | Commercial Coverage | Prior Authorization? | Typical Tier | Patient Cost |
|---|---|---|---|---|
| Generic Topiramate | ✅ Widely covered | Usually NO | Tier 1-2 | $0-$20 copay |
| Brand Topamax | Limited coverage | YES (medical necessity required) | Tier 3-4 | $40+ copay |
| Generic Bupropion | ✅ Widely covered | Usually NO | Tier 1 | $0-$20 copay |
| Brand Wellbutrin | Limited coverage | YES (medical necessity required) | Tier 3-4 | $50+ copay |
Key Insight: Insurance companies strongly prefer generics because they’re clinically equivalent but cost significantly less. When you fill a prescription for generic topiramate or bupropion, you’ll typically pay only your standard generic medication copay—often just a few dollars.
If your doctor prescribes the brand-name version, your insurance will almost certainly require prior authorization to prove that the generic won’t work for you. Without this approval, you could face much higher out-of-pocket costs or outright denial.
If you’re on Medicare, you’ll be pleased to know that topiramate is in a protected class (anticonvulsants), meaning all Part D plans must cover it. Similarly, generic bupropion is covered by 100% of Medicare Part D plans.
Medicare beneficiaries typically pay:
Most Medicare Advantage plans also cover these medications with similar cost-sharing. Brand-name versions may require step therapy (trying the generic first) or prior authorization.
Medicaid coverage varies by state, but topiramate and bupropion generics are widely available across all 50 states. Here’s a snapshot of coverage in key states:
| State | Topiramate Status | Prior Authorization? | Special Restrictions |
|---|---|---|---|
| California | ✅ Covered (Tier 1 preferred) | NO | None beyond standard quantity limits |
| Texas | ✅ Covered (preferred drug) | NO | None |
| Florida | ✅ Covered (preferred) | NO | None |
| New York | ✅ Covered (preferred) | YES (for brand only) | Mandatory generic substitution law applies |
| Pennsylvania | ✅ Covered (preferred) | YES (for brand only) | Generic covered without PA |
| Illinois | ✅ Covered with limits | NO (unless exceeding quantity limits) | Quantity limits: 25mg/50mg (max 6/day); 100mg (4/day); 200mg (2/day) |
Important Note: All six states listed above fully cover topiramate and bupropion generics through Medicaid. Brand-name versions typically require prior authorization with documented medical necessity. No state outright excludes these medications, even for off-label BED treatment.
For Topamax and Wellbutrin generics prescribed for BED, prior authorization is rarely required by commercial insurers or Medicaid. These are well-established, inexpensive generics that insurers routinely cover.
However, you may need prior authorization if:
When prior authorization is needed (such as for controlled medications like Vyvanse), your healthcare provider must submit documentation to your insurance company including:
Approval Timeline: Most insurance companies make prior authorization decisions within 2-5 business days. Urgent requests can be expedited to 24-48 hours.
Common Denial Reasons:
Good News: If your initial request is denied, you can appeal with additional documentation. Many denials are overturned on appeal when providers submit complete medical justification.
Most insured patients pay very little for generic topiramate or bupropion:
These low costs reflect the medications’ generic status and placement on preferred drug lists (typically Tier 1 or Tier 2).
Even without insurance, generic versions remain affordable:
| Medication | Generic Cash Price | GoodRx Discount Price | Brand Cash Price |
|---|---|---|---|
| Topiramate 50mg (60 tablets) | $9-$60 | $5-$15 (as low as $1.80) | ~$800 |
| Bupropion XL 300mg (30 tablets) | $20-$50 | $5-$20 | ~$2,300 |
Money-Saving Strategies:
If you need brand-name versions:
Topamax Savings Card (Janssen):
Wellbutrin XL Savings Card (Bausch):
Patient Assistance Programs:Both Johnson & Johnson (Topamax) and Bausch (Wellbutrin) offer free medication to qualifying uninsured or underinsured patients who meet income requirements. Applications are available through their websites or nonprofit organizations like NeedyMeds and RxAssist.
The rise of telehealth has made BED treatment more accessible than ever. Most insurance plans now cover telehealth visits for mental health conditions at the same rate as in-person appointments.
Commercial Insurance: Major insurers cover video or phone consultations with mental health providers for BED evaluation and medication management. You’ll typically pay your standard specialist copay ($20-50) or coinsurance.
Medicare: Part B permanently covers tele-mental health services. You may need to have had one in-person visit within the past six months, though this requirement is often waived.
Medicaid: All priority states (California, Texas, Florida, New York, Pennsylvania, Illinois) cover telehealth for behavioral health services, often with no patient copay.
Many states have enacted laws requiring insurance companies to cover telehealth services on par with in-person care:
Non-controlled medications like topiramate and bupropion can be prescribed via telehealth without restrictions. Your provider can evaluate you remotely, make a diagnosis, and send prescriptions directly to your pharmacy.
Controlled substances (like Vyvanse) have additional federal requirements. As of 2025, many providers can prescribe these via telehealth under updated DEA guidelines, though some may require an initial in-person evaluation.
Platform note: Services like Klarity Health connect patients with licensed clinicians who can diagnose BED and prescribe appropriate medications through secure video visits—all covered by most insurance plans. With providers available across multiple states and acceptance of both insurance and cash payment, platforms like Klarity make accessing treatment convenient and affordable.
Always request generic topiramate or bupropion rather than brand names. Generics are clinically equivalent, far less expensive, and won’t trigger prior authorization requirements.
Ask your provider to include the correct diagnosis code for Binge Eating Disorder (F50.81) on prescriptions and claims. Proper coding reduces the risk of denial and clarifies medical necessity.
Seeing in-network psychiatrists, psychiatric nurse practitioners, or other mental health professionals ensures maximum coverage and minimal out-of-pocket costs.
Most insurance plans cover therapy for BED (typically 20-30 sessions per year under mental health benefits). Combining medication with evidence-based psychotherapy like CBT produces the best outcomes and demonstrates to insurers that you’re receiving comprehensive treatment.
Maintain records of your diagnosis, treatment history, and response to medications. If you ever need to appeal a denial or request prior authorization, having organized documentation expedites the process.
Before starting treatment, review your insurance plan’s formulary (drug list) online or call member services to confirm coverage details, tier placement, and any requirements.
Even with strong coverage policies, claims occasionally get denied. Here’s what to do:
Call your insurance company’s member services line and ask for a specific reason for denial. Common issues include:
Your doctor’s office can often resolve denials quickly by:
If the denial stands, you have the right to appeal. Your provider can submit additional medical records, treatment notes, and a letter of medical necessity explaining why the medication is essential for your BED treatment.
Success rates: Many appeals succeed when providers submit complete documentation showing the patient meets diagnostic criteria and has tried or cannot use alternative treatments.
If internal appeals fail, most states allow external review by an independent medical expert. This level is rarely needed for topiramate or bupropion generics but can be valuable for more complex cases.
Understanding all your options helps you and your provider choose the best treatment approach:
| Medication | FDA-Approved for BED? | Controlled Substance? | Typical Coverage | Average Cost (Generic) |
|---|---|---|---|---|
| Vyvanse | ✅ Yes | Yes (Schedule II) | Covered with PA | $300-400/month |
| Topiramate | ❌ Off-label | No | Widely covered | $5-20/month |
| Bupropion | ❌ Off-label | No | Widely covered | $5-20/month |
| SSRIs (various) | ❌ Off-label | No | Widely covered | $4-30/month |
Key Takeaway: While Vyvanse is the only FDA-approved medication for BED, topiramate and bupropion offer effective off-label alternatives that are easier to access, more affordable, and don’t require the rigorous monitoring needed for controlled substances.
Will insurance cover off-label use of Topamax or Wellbutrin for BED?
Yes, in most cases. Insurance companies typically cover medications when prescribed by a licensed provider for a medically appropriate indication, even if it’s off-label. The generic versions of these medications are widely covered without requiring special justification.
Do I need prior authorization for generic topiramate or bupropion?
Usually no. Most commercial and government insurance plans cover these generics without prior authorization. PA is typically only required if you’re requesting the brand-name version or unusually high doses.
How much will I pay out-of-pocket with insurance?
With commercial insurance, expect $0-$20 per month for generics. Medicare beneficiaries typically pay $0-$15, and Medicaid often has $0-$3 copays. Your exact cost depends on your specific plan’s formulary tier and cost-sharing structure.
Can I get these medications prescribed through telehealth?
Absolutely. Topiramate and bupropion can be prescribed via telehealth appointments in all 50 states. Insurance covers telehealth visits for mental health at the same rate as in-person appointments under most plans.
What if I can’t afford the medication even with insurance?
If cost is a barrier, ask your pharmacist about:
How do Topamax and Wellbutrin compare to Vyvanse for BED?
Vyvanse is the only FDA-approved medication for BED but requires prior authorization, costs significantly more ($300-400/month), and is a controlled substance with stricter prescribing rules. Topamax and Wellbutrin are used off-label but are much more affordable ($5-20/month generic), easier to access, and effective for many people with BED.
Finding the right medication for Binge Eating Disorder shouldn’t be complicated by insurance uncertainty. The good news is clear: most insurance plans cover generic topiramate and bupropion, making these effective BED treatments accessible and affordable.
Whether you have commercial insurance, Medicare, or Medicaid, you likely have coverage for these medications with minimal out-of-pocket costs. And with telehealth now widely covered, you can access expert evaluation and treatment from the comfort of home.
Ready to explore treatment options? Klarity Health connects you with licensed psychiatric providers who specialize in eating disorders and can prescribe appropriate medications through convenient video visits. With transparent pricing, acceptance of most major insurance plans, and cash-pay options available, Klarity makes getting help straightforward and affordable.
Book your appointment today to discuss whether topiramate, bupropion, or other medications might be right for your BED treatment plan.
UnitedHealthcare Commercial Plans Prior Authorization List – UHC Provider Portal, updated November 2025. Official insurer formulary documenting prior authorization requirements for medications including brand Topamax. Available at: www.uhcprovider.com
California Medi-Cal Rx Formulary – Contra Costa Health Plan Preferred Drug List, revised August 2021, active through 2025. Lists topiramate as Tier 1 preferred medication. Available at: www.scribd.com/document/528831652/Pdl
Illinois Medicaid Preferred Drug List Update – Meridian Health Plan (Centene) Provider Bulletin, November 2025. Documents quantity limits for topiramate prescriptions. Available at: www.ilmeridian.com/providers/pharmacy/preferred-drug-list-updates.html
New York Medicaid Preferred Drug Program – NYS Department of Health Medicaid Fee-for-Service Guide, updated April 2023, in effect 2025. Explains mandatory generic substitution requirements and preferred drug status for topiramate. Available at: studyres.com/doc/7830657/nys-medicaid-fee-for-service-preferred-drug-list
Medicare Coverage of Topamax and Topiramate – Healthline medical review by PharmD Alex Nguyen and Medical News Today review by PharmD Oluwatoyin Kuloyo, July-August 2025. Consumer health articles explaining Medicare Part D coverage of anticonvulsants including topiramate. Available at: www.healthline.com/health/medicare/does-medicare-cover-topamax and www.medicalnewstoday.com/articles/does-medicare-cover-topamax
📅 RESEARCH CURRENCY STATEMENT
Verified as of: December 30, 2025
Formularies checked: UnitedHealthcare (Nov 2025); Cigna (Jan 2025); Blue Cross/Blue Shield (various state PDLs, 2025); Aetna (2025); Humana (2025); Kaiser (2025) – all reflecting 2025 coverage.
Medicaid formularies verified: California (Medi-Cal Rx 2025), Texas (PDL Jan/July 2025), Florida (PDL Oct 2025), New York (Preferred Drug Program 2025), Pennsylvania (Statewide PDL Jul 2025), Illinois (Meridian/State PDL Nov 2025).
GoodRx pricing current as of: Dec 2025 (latest published coupon prices and averages).
Find the right provider for your needs — select your state to find expert care near you.